Wendy Rosamund Brewster (May 24, 1966 – July 24, 2023) was a British-born American gynaecologist who was Professor of Obstetrics and Gynaecology and Director of the Center for Women's Health Research at the University of North Carolina at Chapel Hill.
Brewster started her independent scientific career at University of California, Irvine (UCI), where she studied populations who were at risk for inadequate cancer treatments and outcomes. She looked at how the standard of medical care impacted the outcomes of people with cervical cancer, and demonstrated that cervical dysplasia can be treated with a single visit, overcoming risks of treating high risk populations.[5] Brewster led a National Cancer Institute trial that invited women on low incomes into hospital for a cervical cancer screening, which improved their treatment and follow up rates.[1] In 2007 she was made Director of the Oncology Fellowship programme at UCI.[6]
In 2008 Brewster joined the University of North Carolina at Chapel Hill, where she was made Director for the Center for Women's Health Research.[6][7] She identified bacteria in women's ovaries and fallopian tubes, part of the reproductive tract that was previously understood to be sterile.[8] Brewster also showed that women with ovarian cancer have different bacterial populations to those without cancer, indicating that these bacterial populations may impact cancer progression.[8][9] She was Chair of the Cancer Prevention and Control Committee.[1]
Brewster was the co-director for the Lineberger Comprehensive Cancer Center Equity Council which she helped to initiate in 2020. In this role, she worked on approaches to improve health equity, enhance clinical trial accrual for patients from underrepresented groups and enhance the diversity of the faculty and staff in the Cancer Center.
Death
Wendy Brewster died of pancreatic cancer in Bellaire, Texas, on July 24, 2023, at the age of 57.[10][2]
Selected publications
Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case–control studies[11]
A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24[12]
Diabetic neuropathy, nerve growth factor and other neurotrophic factors[13]